FORM
6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For the month of
July 2010
Commission File
Number: 001-15152
SYNGENTA
AG
(Translation of
registrant’s name into English)
Schwarzwaldallee
215
4058
Basel
Switzerland
(Address of
principal executive offices)
Indicate by check
mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F:
|
Form
20-F
|
X
|
Form
40-F
|
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1):
|
Yes
|
No
|
X
|
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7):
|
Yes
|
No
|
X
|
Indicate by check
mark whether by furnishing the information contained in this Form, the
Registrant is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
|
Yes
|
No
|
X
|
If “Yes” is marked,
indicate below the file number assigned to the registrant in connection with
Rule 12g3-2(b): N/A
Re: SYNGENTA
AG
Press
Release: "Syngenta and Bayer CropScience sign
global cotton technology
licensing agreement"
Herewith we furnish
a press release related to Syngenta AG. The full text of the press release is
the following:
# # #
| Syngenta International AG | Media contact: | Analyst/Investor contacts: | |||
| Media Office | Médard Schoenmaeckers | Jennifer Gough | |||
| CH-4002 Basel | Switzerland | +41 61 323 2323 | Switzerland | +41 61 323 5059 | |
| Switzerland | USA | +1 202 737 6521 | |||
|
Tel:
|
+41
61 323 23 23
|
|
|||
| Fax: | +41 61 323 24 24 |
John
Hudson
Switzerland
|
+41 61 323 6793 | ||
| USA | +1 202 737 6520 | ||||
|
www.syngenta.com
|
|||||
Syngenta
and Bayer CropScience sign global cotton technology licensing
agreement
Syngenta and Bayer
CropScience have entered into a long-term business agreement relating to a key
plant biotechnology trait. Under the agreement, Syngenta has granted Bayer
CropScience a worldwide, non-exclusive license for use of VIPCOTTM insect
control technology in cotton.
The VIPCOT
technology expresses two insecticidal proteins that are highly effective against
a number of important cotton pests, including cotton bollworm (Helicoverpa zea) and tobacco
budworm (Heliothis
virescens). The addition of VIPCOT will complement Bayer’s existing
portfolio of cotton solutions, which includes high-performance cottonseed brands
FiberMax®,
Stoneville® and
Surpass®, and
technologies including LibertyLink® and
GlyTol®
herbicide-tolerance and TwinLink® insect
resistance.
Davor Pisk, Chief
Operating Officer of Syngenta Seeds, said, “This agreement further demonstrates
the innovation that Syngenta is delivering in biotechnology. VIPCOT contains the
same gene as AGRISURE VIPTERA™, to be launched by Syngenta in the US corn market
later this year. The agreement with Bayer CropScience means that cotton growers
will also see an expansion of the technology options available to
them.”
“Bayer is committed
to being a leader in bringing innovative cotton solutions to farmers that help
them tackle tough agronomic challenges and become more productive and
profitable,” said Dr. Joachim Schneider, Head of the BioScience business unit of
Bayer CropScience. “We have one of the most robust cotton technology pipelines
in the business, and we are pleased to be working with Syngenta to advance yet
another insect control technology offering to benefit cotton farmers
worldwide.”
Further details of
the agreement were not disclosed.
Syngenta is one of
the world's leading companies with more than 25,000 employees in over
90 countries dedicated to our purpose: Bringing plant potential to
life. Through world-class science, global reach and commitment to our
customers we help to increase crop
Syngenta – July 14,
2010 / Page 1 of 2
productivity,
protect the environment and improve health and quality of life. For
more information about us please go to www.syngenta.com.
|
Cautionary
Statement Regarding Forward-Looking Statements
This document
contains forward-looking statements, which can be identified by
terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’,
‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions.
Such statements may be subject to risks and uncertainties that could cause
the actual results to differ materially from these statements. We refer
you to Syngenta's publicly available filings with the U.S. Securities and
Exchange Commission for information about these and other risks and
uncertainties. Syngenta assumes no obligation to update forward-looking
statements to reflect actual results, changed assumptions or other
factors. This document does not constitute, or form part of, any offer or
invitation to sell or issue, or any solicitation of any offer, to purchase
or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor
shall it form the basis of, or be relied on in connection with, any
contract therefor.
|
Syngenta – July 14,
2010 / Page 2 of 2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
SYNGENTA
AG
|
||||||
|
Date:
|
July 14,
2010
|
By:
|
/s/ Tobias
Meili
|
|||
|
Name:
|
Tobias
Meili
|
|||||
| Title: | Head Corporate Legal Affairs | |||||
|
By:
|
/s/ Brigitte
Benz
|
|||||
|
Name:
|
Brigitte
Benz
|
|||||
|
Title:
|
Deputy Head
Shareholder Services & Group Administration
|
|||||